Current approaches for the disease often depend on injections of GLP-1 medications, a process that can be burdensome for individuals. Experts are diligently developing advanced release systems to improve person compliance and results. These include ingested formulations, inhaled delivery, and even long-acting devices, offering a less and perhaps mo

New Evidence Shows 22.8% Weight Loss in Long-term Study The SURMOUNT-4 trial has shown remarkable results for eco-friendly weight management. Our analysis of this landmark study reveals that participants lost an impressive 25.3% of their weight with tirzepatide, whereas the placebo group achieved only 9.9%. Maintaining weight loss has always bee